duloxetine hydrochloride has been researched along with Anxiety Neuroses in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 25 (46.30) | 29.6817 |
| 2010's | 26 (48.15) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Zhang, K; Zhu, J | 1 |
| Baldwin, DS; Fagan, HA | 1 |
| Chen, SY; Gao, BL; Gao, HM; Han, N; Huang, XB; Jiang, SS; Law, S; Li, ZW; Xiao, JP; Xie, ZJ; Zhang, Y | 1 |
| Chirila, M; Duna, SN; Ghita, A; Iordachescu, A; Rizea-Savu, S | 1 |
| Parlakkaya Yıldız, FB; Şahan, E | 1 |
| Alten, R; Bär, KJ; Bernateck, M; Brückle, W; Friedel, E; Häuser, W; Henningsen, P; Petzke, F; Sommer, C; Tölle, T; Üçeyler, N; Winkelmann, A | 1 |
| Du, H; Fang, S; Li, X; Liu, J; Wang, C; Zhou, C; Zhu, L | 1 |
| Alag, P; Balasubramaniam, M; Gupta, A; Gupta, S; Joshi, P; Maher, S; Tampi, D; Tampi, RR; Young, J | 1 |
| Cohen, LS; Connors, S; Freeman, MP; Hirschberg, AM; Joffe, H; Petrillo, LF; Regan, S; Wang, B | 1 |
| Franzen, MD; Kaplan, A; Lebovitz, PJ; Nickell, PV; Ransom, D | 1 |
| Arkoub, H; Augendre-Ferrante, B; Evans, D; Pamulapati, S; Perrot, S; Picard, H; Rouillon, F; Valensi, P | 1 |
| Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Simon, JS | 1 |
| Ahl, J; Alaka, KJ; Ball, S; Bidzan, L; Dorn, B; Dueñas, H; Lenox-Smith, A; Montejo, A; Munshi, A; Noble, W; Strawn, JR | 1 |
| Cai, N; Findling, RL; Pangallo, BA; Prakash, A; Strawn, JR; Stroud, CE; Zhang, Q | 1 |
| Ball, SG; Escobar, R; Lipsius, S | 1 |
| Huang, G; Liang, W; Wang, C; Yang, S; Zhang, L; Zhang, Y | 1 |
| Chen, SL; Long, S; Mao, HJ; Ren, WW; Tang, GZ; Xu, MM; Zhou, ZY | 1 |
| Ball, SG; Davidson, JR; Detke, M; Erickson, J; Llorca, PM; Russell, JM; Wittchen, HU | 1 |
| Allgulander, C; Nutt, D | 1 |
| Allgulander, C; Lecrubier, Y; Nutt, D; Peters, T; Wittchen, U | 1 |
| Allgulander, C; Ball, S; Detke, M; Erickson, J; Nutt, D; Russell, J; Spann, M; Walker, D | 1 |
| Mallinckrodt, CH; Meyers, AL; Prakash, A; Robinson, MJ; Russell, JM; Sheehan, DV; Swindle, RW | 1 |
| Lin, CC | 1 |
| Ball, SG; Bodkin, JA; Llorca, PM; Russell, JM; Spann, M | 1 |
| Ball, SG; Crits-Christoph, P; Kornstein, SG; Russell, JM; Spann, ME | 1 |
| Bobrova, MV; Listopadov, IuI; Rzheusskaia, GV; Umrudina, AG | 1 |
| Carter, NJ; McCormack, PL | 1 |
| Ball, S; Beesdo, K; Hartford, J; Russell, J; Spann, M; Wittchen, HU | 1 |
| Nelson, JC | 2 |
| Mancini, M; Perna, G; Petralia, A; Rossi, A | 1 |
| Brandes, M; Delong, H; Hoge, EA; Marks, EH; Moshier, SJ; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Brecht, S; Crucitti, A; Nilsson, M; Wernicke, J; Yang, CR; Zhang, Q | 1 |
| Harnett-Sheehan, K; Prakash, A; Sheehan, DV; Spann, ME; Thompson, HF | 1 |
| Locati, E; Pierò, A | 1 |
| Allgulander, C; Ball, SG; Bodkin, JA; Llorca, PM; Russell, JM; Spann, ME; Walker, DJ | 1 |
| Ang, QQ; Ball, SG; Desaiah, D; Wang, G; Wu, WY | 1 |
| Dharia, S; Fijal, B; Houston, JP; Perlis, RH | 1 |
| Alten, R; Bär, KJ; Häuser, W; Petzke, F; Sommer, C; Späth, M; Tölle, T; Uçeyler, N; Winkelmann, A; Winter, E | 1 |
| Ball, S; Lipsius, S; Marangell, LB; Russell, JM | 1 |
| Bailey, KP | 1 |
| De Las Cuevas, C; Sanz, EJ | 1 |
| Gahimer, J; Ossanna, MJ; Viktrup, L; Wernicke, J; Wulster-Radcliffe, M; Yalcin, I | 1 |
| Ball, S; Detke, MJ; Dinkel, J; Erickson, J; Raskin, J; Rickels, K; Russell, J; Rynn, M | 1 |
| Ball, S; Detke, M; Dinkel, J; Dunayevich, E; Erickson, J; Hartford, J; Kornstein, S; Liebowitz, M; Pigott, T; Russell, J; Walker, D | 1 |
| Kajdasz, DK; Lledó, A; Raskin, J; Wang, F; Wernicke, J | 1 |
| Ball, SG; Detke, MJ; Endicott, J; Erickson, J; Marciniak, M; Raskin, J; Russell, JM; Swindle, RW | 1 |
| Crippa, JA; Filho, AS; Freitas, MC; Zuardi, AW | 1 |
| Allgulander, C; Ball, S; Erickson, J; Hartford, J; Raskin, J; Russell, J; Rynn, M | 1 |
| D'Souza, DN; Erickson, JS; Fava, M; Hartford, JT; Russell, JM; Weisberg, R | 1 |
| Ball, S; Detke, M; Endicott, J; Liebowitz, M; Pollack, MH; Russell, J; Spann, M; Swindle, R | 1 |
| Crits-Christoph, P; Kornstein, SG; Pollack, MH; Raskin, J; Russell, JM; Spann, ME | 1 |
| Allgulander, C; Carlson, J; Davidson, J; Erickson, JS; Hartford, J; Perahia, D; Pollack, MH; Raskin, J; Russell, JM; Wohlreich, MM | 1 |
| Bakish, D; Ball, S; Duenas, H; Erickson, J; Hallberg, C; Nicolini, H; Russell, JM; Sagman, D; Spann, M | 1 |
15 review(s) available for duloxetine hydrochloride and Anxiety Neuroses
| Article | Year |
|---|---|
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Duloxetine Hydrochloride; Humans; Pregabalin; Treatment Outcome | 2023 |
[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].
Topics: Amitriptyline; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; Fibromyalgia; Germany; Humans; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Societies, Medical | 2017 |
Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Drug Administration Schedule; Duloxetine Hydrochloride; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Antidepressants for anxiety disorders in late-life: A systematic review.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Citalopram; Duloxetine Hydrochloride; Humans; Late Onset Disorders; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.
Topics: Antidepressive Agents; Anxiety Disorders; Duloxetine Hydrochloride; Female; Humans; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Duloxetine in the treatment of generalized anxiety disorder.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Clinical Trials as Topic; Duloxetine Hydrochloride; Humans; Thiophenes | 2009 |
Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Topics: Antidepressive Agents; Anxiety Disorders; Databases, Bibliographic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Duloxetine Hydrochloride; Humans; Meta-Analysis as Topic; Thiophenes; Treatment Outcome | 2009 |
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
Topics: Animals; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Quality of Life; Thiophenes | 2010 |
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
Topics: Antidepressive Agents; Anxiety Disorders; Blood Glucose; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Glycemic Index; Humans; Hyperglycemia; Male; Middle Aged; Mood Disorders; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2010 |
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
Topics: Amitriptyline; Analgesics; Analgesics, Opioid; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Germany; Humans; Interdisciplinary Communication; Off-Label Use; Patient Care Team; Pregabalin; Somatoform Disorders; Thiophenes | 2012 |
Physical symptoms comorbid with depression and the new antidepressant duloxetine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Gastrointestinal Diseases; Humans; Mood Disorders; Norepinephrine; Pain; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2003 |
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence | 2007 |
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Severity of Illness Index; Statistics as Topic; Thiophenes; Treatment Outcome | 2007 |
Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pain; Pain Measurement; Personality Inventory; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2008 |
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
Topics: Anxiety Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Endpoint Determination; Female; Humans; Male; Multicenter Studies as Topic; Neurotransmitter Uptake Inhibitors; Placebos; Psychiatric Status Rating Scales; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2008 |
24 trial(s) available for duloxetine hydrochloride and Anxiety Neuroses
| Article | Year |
|---|---|
The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotherapy, Group; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Young Adult | 2019 |
The Effect of Food on the Single-Dose Bioavailability and Tolerability of the Highest Marketed Strength of Duloxetine.
Topics: Adult; Anxiety Disorders; Biological Availability; Cross-Over Studies; Depressive Disorder, Major; Diabetic Neuropathies; Drug Compounding; Duloxetine Hydrochloride; Fasting; Female; Food; Food-Drug Interactions; Humans; Male; Middle Aged; Safety; Serotonin and Noradrenaline Reuptake Inhibitors; Therapeutic Equivalency; Treatment Outcome | 2020 |
Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Hot Flashes; Humans; Menopause; Middle Aged; Patient Selection; Severity of Illness Index; Thiophenes | 2013 |
An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Comorbidity; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Placebos; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Single-Blind Method; Thiophenes; Young Adult | 2014 |
Prescribing patterns of duloxetine in France: a prescription assessment study in real-world conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Contraindications; Depressive Disorder, Major; Drug Utilization; Duloxetine Hydrochloride; Female; France; Humans; Male; Middle Aged; Thiophenes | 2014 |
A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Young Adult | 2014 |
Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2014 |
A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Topics: Adolescent; Anxiety Disorders; Child; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Mexico; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; South Africa; Suicidal Ideation; Treatment Outcome; United States | 2015 |
Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety; Anxiety Disorders; Argentina; Austria; Canada; Depression; Double-Blind Method; Duloxetine Hydrochloride; Female; Germany; Humans; Male; Mexico; Poland; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Spain; Treatment Outcome; United Kingdom; United States | 2015 |
[Treatment of Persistent Somatoform Pain Disorder by Floating Needle Therapy and Duloxetine].
Topics: Acupuncture Therapy; Analgesics; Anxiety Disorders; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Needles; Pain; Pain Management; Pain Measurement; Psychiatric Status Rating Scales; Somatoform Disorders; Treatment Outcome | 2016 |
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Secondary Prevention; Thiophenes; Time Factors | 2008 |
The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Psychophysiologic Disorders; Thiophenes; Treatment Outcome | 2008 |
A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
Topics: Analysis of Variance; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Longitudinal Studies; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Research Design; Secondary Prevention; Thiophenes; Time Factors | 2009 |
Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response.
Topics: Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Humans; Thiophenes; Treatment Outcome | 2010 |
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Topics: Antidepressive Agents; Anxiety Disorders; Comorbidity; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Humans; Outpatients; Placebos; Psychiatric Status Rating Scales; Psychometrics; Thiophenes; Time Factors; Treatment Outcome | 2011 |
An open, non-randomised comparison of escitalopram and duloxetine for the treatment of subjects with Generalized Anxiety Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Anxiety Disorders; Citalopram; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Dropouts; Personality Disorders; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2011 |
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Secondary Prevention; Thiophenes; Treatment Outcome | 2011 |
Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes; Treatment Outcome | 2011 |
Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
Topics: Adolescent; Adult; Aged; Agoraphobia; Analysis of Variance; Antidepressive Agents; Anxiety Disorders; Brain-Derived Neurotrophic Factor; China; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Endpoint Determination; Female; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders; Psychiatric Status Rating Scales; Stress, Psychological; Thiophenes; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2008 |
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
Topics: Adult; Anxiety Disorders; Disabled Persons; Double-Blind Method; Duloxetine Hydrochloride; Female; Health Status; Humans; Male; Quality of Life; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2007 |
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.
Topics: Adult; Anxiety Disorders; Diagnostic and Statistical Manual of Mental Disorders; Duloxetine Hydrochloride; Endpoint Determination; Female; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome | 2008 |
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
Topics: Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Psychophysiologic Disorders; Psychotherapy; Surveys and Questionnaires; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2009 |
15 other study(ies) available for duloxetine hydrochloride and Anxiety Neuroses
| Article | Year |
|---|---|
Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder.
Topics: Anxiety; Anxiety Disorders; C-Reactive Protein; Comorbidity; Depression; Duloxetine Hydrochloride; Flunarizine; Humans; Interleukin-6; Migraine Disorders; Tumor Necrosis Factor-alpha | 2022 |
Duloxetine Induced Hyponatremia.
Topics: Antidepressive Agents; Anxiety Disorders; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Middle Aged; Serotonin and Noradrenaline Reuptake Inhibitors | 2019 |
Wine and drug evaluations: lessons on making comparisons of noninferiority.
Topics: Anxiety Disorders; Cross-Cultural Comparison; Cyclohexanols; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Europe; Humans; Placebo Effect; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride; Wine | 2008 |
Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.
Topics: Antidepressive Agents; Anxiety Disorders; Consensus Development Conferences as Topic; Cyclohexanols; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2008 |
A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Data Interpretation, Statistical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2008 |
Duloxetine treatment of social anxiety disorder with comorbid major depression.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2008 |
[Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy].
Topics: Adult; Aged; Antidepressive Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Syndrome; Thiophenes; Treatment Outcome | 2009 |
The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Secondary Prevention; Somatoform Disorders; Thiophenes; Treatment Outcome | 2009 |
Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Personality Inventory; Prognosis; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Thiophenes; Treatment Outcome | 2010 |
Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Logistic Models; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Severity of Illness Index; Thiophenes; Treatment Outcome | 2011 |
Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Biomarkers, Pharmacological; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Genetic Association Studies; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, Corticotropin-Releasing Hormone; Thiophenes | 2013 |
Duloxetine-induced excessive disturbing and disabling yawning.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Yawning | 2007 |
A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anxiety Disorders; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Thiophenes; United States; Urinary Incontinence, Stress | 2007 |
Duloxetine in the treatment of social anxiety disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2007 |
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
Topics: Adrenergic Uptake Inhibitors; Aged; Anxiety Disorders; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2008 |